跳至主要内容
临床试验/NCT00750308
NCT00750308已完成不适用

Renin Angiotensin Aldosterone System (RAAS) and Fibrinolysis in Humans: ACEi

Vanderbilt University0 个研究点目标入组 27 人开始时间: 2006年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
27
主要终点
Beta Cell Function

研究概览

简要总结

This study will measure the effect of the agent tadalafil on glucose and insulin homeostasis in people with metabolic syndrome in the presence and absence of an ACE inhibitor.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ambulatory subjects, 18 to 70 years of age, inclusive
  • For female subjects, the following conditions must be met:
  • Postmenopausal status for at least 1 year,
  • Status-post surgical sterilization, or
  • If of childbearing potential, utilization of adequate birth control, and willingness to undergo urine beta-hcg testing prior to drug treatment and on every study day
  • Metabolic syndrome as defined by 3 or more of the following:
  • Fasting plasma glucose of at least 100 mg/dL (5.5 mmol/L),
  • Serum triglycerides of at least 150 mg/dL (1.7 mmol/L),
  • Serum HDL cholesterol less than 40 mg/dL (1.04 mmol/L) in males and less than 50mg/dl (1.30mmol/L) in females,
  • Blood pressure of at least 130/85 mmHg, or
  • Waist girth of more than 102 cm in men or 88 cm in women
  • Exclusion criteria:
  • Subjects presenting with any of the following will not be included in the study:
  • Diabetes type 1 or type 2, as defined by a fasting glucose of 126 mg/dL or greater or the use of anti-diabetic medication
  • Use of hormone replacement therapy
  • Statin therapy
  • In hypertensive subjects, a seated systolic blood pressure greater than 179 mmHg or a seated diastolic blood pressure greater than 110 mmHg
  • Breast-feeding
  • Cardiovascular disease such as myocardial infarction within 6 months prior to enrollment, presence of angina pectoris, significant arrhythmia, congestive heart failure (LV hypertrophy acceptable), deep vein thrombosis, pulmonary embolism, second or third degree heart block, mitral valve stenosis, aortic stenosis or hypertrophic cardiomyopathy
  • Treatment with anticoagulants
  • History of serious neurologic disease such as cerebral hemorrhage, stroke, or transient ischemic attack
  • History or presence of immunological or hematological disorders
  • Diagnosis of asthma
  • Clinically significant gastrointestinal impairment that could interfere with drug absorption
  • Impaired hepatic function (aspartate amino transaminase [AST] and/or alanine amino transaminase [ALT] > 1.5 x upper limit of normal range)
  • Impaired renal function (serum creatinine > 1.5 mg/dl)
  • Hematocrit < 35%
  • Any underlying or acute disease requiring regular medication which could possibly pose a threat to the subject or make implementation of the protocol or interpretation of the study results difficult
  • Treatment with chronic systemic glucocorticoid therapy (more than 7 consecutive days in 1 month)
  • Treatment with lithium salts
  • History of alcohol or drug abuse
  • Treatment with any investigational drug in the 1 month preceding the study
  • Mental conditions rendering the subject unable to understand the nature, scope and possible consequences of the study
  • Inability to comply with the protocol, e.g. uncooperative attitude, inability to return for follow-up visits, and unlikelihood of completing the study

排除标准

  • 未提供

研究组 & 干预措施

tadalafil, ramapril, combo, placebo

Active Comparator

placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, ramipril + tadalafil, washout, placebo+placebo for three weeks

干预措施: Ramipril (Drug)

tadalafil, ramapril, combo, placebo

Active Comparator

placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, ramipril + tadalafil, washout, placebo+placebo for three weeks

干预措施: Tadalafil (Drug)

tadalafil, ramapril, combo, placebo

Active Comparator

placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, ramipril + tadalafil, washout, placebo+placebo for three weeks

干预措施: placebo (Drug)

ramipril, tadalafil, placebo, combo

Active Comparator

placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: Ramipril (Drug)

ramipril, tadalafil, placebo, combo

Active Comparator

placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: Tadalafil (Drug)

ramipril, tadalafil, placebo, combo

Active Comparator

placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: placebo (Drug)

combo, placebo, tadalafil, ramipril

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks

干预措施: Ramipril (Drug)

combo, placebo, tadalafil, ramipril

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks

干预措施: Tadalafil (Drug)

combo, placebo, tadalafil, ramipril

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks

干预措施: placebo (Drug)

placebo, combo, ramipril, tadalafil

Active Comparator

placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks, washout placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks

干预措施: Ramipril (Drug)

placebo, combo, ramipril, tadalafil

Active Comparator

placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks, washout placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks

干预措施: Tadalafil (Drug)

placebo, combo, ramipril, tadalafil

Active Comparator

placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks, washout placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks

干预措施: placebo (Drug)

tadalafil, placebo, ramipril, combo

Active Comparator

placebo+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+ramipril for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: Ramipril (Drug)

tadalafil, combo, placebo, ramipril

Active Comparator

placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+ramipril for three weeks

干预措施: placebo (Drug)

tadalafil, placebo, ramipril, combo

Active Comparator

placebo+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+ramipril for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: Tadalafil (Drug)

tadalafil, placebo, ramipril, combo

Active Comparator

placebo+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+ramipril for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: placebo (Drug)

ramipril, combo, tadalfil, placebo

Active Comparator

placebo+ramipril for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo for three weeks

干预措施: Ramipril (Drug)

ramipril, combo, tadalfil, placebo

Active Comparator

placebo+ramipril for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo for three weeks

干预措施: Tadalafil (Drug)

ramipril, combo, tadalfil, placebo

Active Comparator

placebo+ramipril for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo for three weeks

干预措施: placebo (Drug)

placebo, tadalafil, combo, ramipril

Active Comparator

placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+ramipril for three weeks

干预措施: Ramipril (Drug)

combo, ramipril, placebo, tadalafil

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks

干预措施: Ramipril (Drug)

combo, ramipril, placebo, tadalafil

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks

干预措施: Tadalafil (Drug)

combo, ramipril, placebo, tadalafil

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks

干预措施: placebo (Drug)

placebo, tadalafil, combo, ramipril

Active Comparator

placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+ramipril for three weeks

干预措施: Tadalafil (Drug)

placebo, tadalafil, combo, ramipril

Active Comparator

placebo+placebo for three weeks, washout, placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+ramipril for three weeks

干预措施: placebo (Drug)

tadalafil, combo, placebo, ramipril

Active Comparator

placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+ramipril for three weeks

干预措施: Ramipril (Drug)

tadalafil, combo, placebo, ramipril

Active Comparator

placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+placebo for three weeks, washout, placebo+ramipril for three weeks

干预措施: Tadalafil (Drug)

ramipril, placebo, combo, tadalafil

Active Comparator

placebo+ramipril for three weeks, washout, placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks

干预措施: Ramipril (Drug)

ramipril, placebo, combo, tadalafil

Active Comparator

placebo+ramipril for three weeks, washout, placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks

干预措施: Tadalafil (Drug)

ramipril, placebo, combo, tadalafil

Active Comparator

placebo+ramipril for three weeks, washout, placebo+placebo for three weeks, washout, ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks

干预措施: placebo (Drug)

combo, tadalafil, ramipril, placebo

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+placebo for three weeks

干预措施: Ramipril (Drug)

combo, tadalafil, ramipril, placebo

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+placebo for three weeks

干预措施: Tadalafil (Drug)

combo, tadalafil, ramipril, placebo

Active Comparator

ramipril+tadalafil for three weeks, washout, placebo+tadalafil for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+placebo for three weeks

干预措施: placebo (Drug)

placebo, ramipril, tadalafil, combo

Active Comparator

placebo+placebo for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: Ramipril (Drug)

placebo, ramipril, tadalafil, combo

Active Comparator

placebo+placebo for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: Tadalafil (Drug)

placebo, ramipril, tadalafil, combo

Active Comparator

placebo+placebo for three weeks, washout, placebo+ramipril for three weeks, washout, placebo+tadalafil for three weeks, washout, ramipril+tadalafil for three weeks

干预措施: placebo (Drug)

结局指标

主要结局

Beta Cell Function

时间窗: 3 hours

Beta cell function as measured during a frequently sampled IV glucose tolerance test

Insulin Sensitivity

时间窗: three weeks

As assessed using IV glucose tolerance test and calculated using Min Mod units mU/mm

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nancy J. Brown

Professor of Medicine

Vanderbilt University

相似试验